CustomerInsights.AI Founder & CEO Abhay Jajoo Named a 2026 Phoenix Titan 100 Honoree

Titan CEO's Titan 100 Program Honors Abhay Jajoo's Leadership and Contributions to AI-Driven Innovation in Life Sciences.

<span id="hs_cos_wrapper_name" class="hs_cos_wrapper hs_cos_wrapper_meta_field hs_cos_wrapper_type_text" style="" data-hs-cos-general-type="meta_field" data-hs-cos-type="text" >CustomerInsights.AI Founder & CEO Abhay Jajoo Named a 2026 Phoenix Titan 100 Honoree</span>

Phoenix, AZ, June 25, 2026 CustomerInsights.AI today announced that Founder & CEO Abhay Jajoo has been named a 2026 Phoenix Titan 100 Honoree, recognizing his visionary leadership and commitment to making AI-driven commercial insights more accessible and actionable for life sciences organizations worldwide.

A Milestone for CIAI and Its Mission

CustomerInsights.AI (CIAI), the Platform-Led Analytics-as-a-Service (PLAaaS) company built exclusively for the life sciences industry, is proud to announce that its Founder & CEO, Abhay Jajoo, has been named a 2026 Phoenix Titan 100 honoree. The distinction places Abhay among the Phoenix region’s leading executives for his leadership, innovation and business impact across the life sciences analytics industry.

The recognition comes at a time when life sciences organizations are increasingly investing in AI-driven analytics and agentic technologies to improve decision-making, operational efficiency, and commercial effectiveness. Under Abhay's leadership, CIAI has been at the forefront of helping pharmaceutical and biotech companies modernize their analytics ecosystems through AI-powered platforms and services.

Together, the 2026 Phoenix Titan 100 honorees and their companies generate more than $10 billion in annual revenue and employ over 60,000 people across the region and beyond. Honorees will be published in a limited-edition Titan 100 book, profiled exclusively online, and celebrated at the annual awards ceremony on September 24th, 2026, at Chateau Luxe Event Venue — Phoenix’s most prestigious gathering of business leaders.

Driving Innovation in Life Sciences Analytics

Since founding CustomerInsights.AI in 2018, Abhay has led the company's growth into a global organization of more than 170 professionals across North America and India. Today, CIAI partners with leading pharmaceutical and biotech organizations to help modernize commercial analytics, improve decision-making, and accelerate business outcomes through AI-driven intelligence.

Under Abhay's leadership, CIAI launched two flagship platforms—ciPARTHENON™, its Commercial Analytics Cloud, and ciATHENA, its Agentic AI platform—helping life sciences organizations unify commercial intelligence, automate analytics workflows, and accelerate decision-making.

CIAI's recent milestones include recognition as a Gartner Sample Vendor in Agentic Analytics for Life Sciences, a 2026 Artificial Intelligence Excellence Award for Agentic AI innovation, and recognition from PMSA for Advanced Machine Learning and Deep Learning. These recognitions reflect the company's continued focus on delivering measurable impact through AI-powered analytics.

The Titan 100 recognition reflects not only Abhay's leadership, but also CIAI's continued growth and innovation in helping life sciences organizations unlock greater value from data, analytics, and AI.

Humbled and honored to be named a 2026 Titan 100 honoree. This recognition isn't mine alone—it belongs to our incredible team across North America and India who show up every day with ownership, curiosity, and heart. It belongs to the partners and clients who trusted us early, and to everyone who believed that data should be accessible and actionable for every decision-maker, not just a select few. I'm grateful for this milestone, and even more excited for what's ahead as we keep building toward a future where AI-driven insights help bring life-changing therapies to patients faster.
Abhay Jajoo Founder & CEO, CustomerInsights.AI
This year's Titans represent more than success; they embody resilience, purpose, and transformation. Being a Titan is not just a title; it is a mindset, a way of leading with courage, serving with integrity, and creating something that outlasts you. These leaders stand as proof that the future of business is driven by those who turn vision into lasting impact.
Jaime Zawmon President, Titan CEO

View the full awards announcement

About the Titan 100 Program

Titan CEO is the creator of the Titan 100 program. The Titan 100 is a national program operating across 12 markets throughout the United States that recognizes the top 100 CEOs and C-level executives in each region. Representing both the private and public sectors, these Titans of Industry demonstrate exceptional leadership, vision, passion, and influence in their field. The Titan 100 are recognized at an annual awards event, published in the Titan 100 book, and given the opportunity to build relationships with their fellow Titans by connecting multiple times throughout the year. Titans must be nominated and selected annually, with the pinnacle achievement of being recognized as an elite Hall of Fame honoree in their third year. The Titan 100 is one of the fastest-growing, most powerful communities of executives across the nation.

About CustomerInsights.AI

CustomerInsights.AI is a platform-led analytics-as-a-service company built exclusively for the life sciences industry. Founded in 2018 by pharma and analytics leaders, the company was built on the belief that AI should become a core operational capability rather than a standalone innovation initiative. CIAI has pioneered a Platform-Led Analytics-as-a-Service (PLAaaS) model, combining technology, deep domain expertise, and AI-driven intelligence to deliver measurable commercial outcomes for life sciences organizations.

Its flagship platforms, ciPARTHENON™ and ciATHENA, help pharmaceutical and biotech organizations modernize analytics ecosystems, reduce operational complexity, and improve commercial decision-making through AI-powered intelligence.

CIAI serves clients ranging from emerging biotech companies to some of the world's leading pharmaceutical organizations through teams across North America and India.